Effect of Ayurvedic Medicated Retention Enema in Parkinsons Disease when compared to Conventional Treatment

Effect of Ashwagandha Ghritha Matra Vasti (Retention Enema) in Parkinsons Disease As An Add on Treatment To Levodopa Carbidopa- A comparitive clinical trial - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055050

Enrollment

Registered

2023-07-11

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G20- Parkinsons disease

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Scores Of Tremor,Rigidity,Bradykinesia,Postural Instability And Non Motor Symptoms Not More Than 3

Exclusion criteria

Exclusion criteria: 1.Using Drugs For Other Systemic Illness 2.Other Neurological Illness Or Treatment 3.Haemarrhoids 4.Pregnancy 5.Wheel Chair Bound/Bedridden

Design outcomes

Primary

Measure	Time frame
Changes in scores of UPDR scaleTimepoint: 0th Day 14th Day 42ND Day	—

Secondary

Measure	Time frame
Cell line study of Ashwagandha ghrithaTimepoint: 1 month ;Standardize raw drug AshwagandhaTimepoint: 1 Month	—

Countries

India

Contacts

Public ContactT K Sujan

govt ayurveda college trivandrum

shilpathengil94@gmail.com8129787020

Outcome results